MDT Stock Recent News

Medical device manufacturer Medtronic (MDT 2.59%) is a healthcare industry stalwart. The company, based in the U.S. and Ireland, is one of the largest in its segment, developing and selling a diverse portfolio of products that includes hospital equipment and devices for cardiovascular care and diabetes.

You have $1,000 (or $200 or $50,000) burning a hole in your pocket and you're itching to invest in some stocks. Might I suggest some dividend payers?

Shares of Medtronic (MDT -6.63%) were sinking 7.3% as of 11:21 a.m. ET on Tuesday.

Pre-market futures are starting a new holiday-shortened trading week higher, with all four major indexes currently riding in the green. The Dow is +81 points at this hour, the S&P 500 is +23, the Nasdaq +96 points and the small-cap Russell 2000 +9.

Medtronic plc (NYSE:MDT ) Q3 2025 Earnings Conference Call February 18, 2025 8:00 AM ET Company Participants Ryan Weispfenning - Vice President and Head of Investor Relations Geoff Martha - Chairman and Chief Executive Officer Gary Corona - Interim Chief Financial Officer Brad Welnick - Vice President, Investor Relations Sean Salmon - Executive Vice President and President, Cardiovascular Portfolio Mike Marinaro - Executive Vice President and President, Medical Surgical Portfolio and Americas Conference Call Participants Patrick Wood - Morgan Stanley Larry Biegelsen - Wells Fargo Robbie Marcus - JP Morgan Vijay Kumar - Evercore ISI Travis Steed - Bank of America Matt Miksic - Barclays Josh Jennings - TD Cowen David Rescott - Baird Shagun Singh - RBC Capital Markets Pito Chickering - Deutsche Bank Ryan Weispfenning Good morning. I'm Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations, and I appreciate that you're joining us for our Fiscal ‘25 Third Quarter Video

The headline numbers for Medtronic (MDT) give insight into how the company performed in the quarter ended January 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

MDT delivers strong earnings in the fiscal 2025 third quarter, with significant improvements in both gross and operating margins.

Tuesday, Medtronic Plc MDT reported third-quarter 2025 sales of $8.29 billion, missing the consensus of $8.32 billion.

Medtronic (MDT) came out with quarterly earnings of $1.39 per share, beating the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.30 per share a year ago.

Medtronic said it is “starting to see the results” of its investment in new products.